Paul Bessette

Title: Paul Bessette: Innovator in Immune Modulation

Introduction

Paul Bessette is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of immunology through his innovative work on immune cell modulation. His research focuses on the development of novel therapeutic agents that can selectively influence immune responses.

Latest Patents

Paul Bessette holds a patent for "Fusions with CD8 antigen binding molecules for modulating immune cell function." This patent describes anti-CD8 antigen binding molecules and fusion polypeptides that selectively modulate the function of CD8+ T cells over other immune cells. The patent also includes polynucleotides encoding these antigen binding molecules and fusion polypeptides, as well as vectors and host cells that incorporate such polynucleotides. Furthermore, it outlines methods for producing these molecules, pharmaceutical compositions that include them, and their various uses.

Career Highlights

Paul Bessette is currently associated with Asher Biotherapeutics, Inc., where he continues to advance his research in immunotherapy. His work is pivotal in developing new strategies for treating diseases that involve immune dysfunction.

Collaborations

Some of his notable coworkers include Yik Andy Yeung and Ivana Djuretic, who collaborate with him on various projects aimed at enhancing immune cell functionality.

Conclusion

Paul Bessette's innovative contributions to the field of immunology, particularly through his patent on CD8 antigen binding molecules, highlight his role as a key figure in advancing therapeutic strategies for immune modulation. His work at Asher Biotherapeutics, Inc. continues to pave the way for future developments in this critical area of medicine.